INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP

▤ Summary

Pomerantz LLP says a class action has been filed against Medpace Holdings over alleged securities fraud and other unlawful business practices. The notice tells investors who bought Medpace securities during the class period that they may seek appointment as lead plaintiff by June 8, 2026. The article points to Medpace’s February 2026 earnings release and says the market reacted sharply after the company reported a book-to-bill ratio below guidance. This is a legal and investor-relations update, not a product or corporate transaction announcement.

▦ Linked Companies